Michael Frederic Grunebaum MD
Associate Professor of Psychiatry at Columbia University Medical Center
Join to View Full Profile
200 W 90th St Apt 1gNew York, NY 10024
Phone+1 212-580-4252
Fax+1 888-947-4677
Dr. Grunebaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1992 - 1995
Mount Auburn HospitalInternship, Internal Medicine, 1991 - 1992
Harvard Medical SchoolClass of 1991
Certifications & Licensure
NY State Medical License 1992 - 2025
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression Start of enrollment: 2004 Jun 01
- Ketamine in the Treatment of Suicidal Depression Start of enrollment: 2012 Jun 01
- Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical trials since 2020 of rapid anti-suicidal ideation effects of ketamine and its enantiomers: a systematic review.Sumra Sajid, J John Mann, Michael F Grunebaum
Translational Psychiatry. 2025-02-06 - 4 citationsAcute Dissociation and Ketamine's Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial.Sumra Sajid, Hanga C Galfalvy, John G Keilp, Ainsley K Burke, J John Mann
The International Journal of Neuropsychopharmacology. 2024-04-01 - Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale.Sumra Sajid, Ryan E Lawrence, Hanga C Galfalvy, John G Keilp, Vivek K Moitra
Journal of Affective Disorders Reports. 2024-01-01
Press Mentions
Altered Coupling of Spontaneous Brain Activities and Brain Temperature in Patients with Adolescent-Onset, First-Episode, Drug-Naïve SchizophreniaMarch 6th, 2020
Can We Stop Suicides?November 30th, 2018
Ketamine May Reduce Suicidal Thoughts: StudyDecember 15th, 2017- Join now to see all
Grant Support
- IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trialNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2020–2026
- Paroxetine/Bupropion In Suicide Attempters/Ideators With Major DepressionNational Institute Of Mental Health2009–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
